Skip to main content

Find Clinical Trials

Home
Conditions
Adrenal Cortex Neoplasms

Clinical trial condition

Adrenal Cortex Neoplasms

Explore clinical trials studying Adrenal Cortex Neoplasms. Study availability and eligibility vary by location and protocol.

76 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Adrenal Cortex Neoplasms trial results

Recruiting

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

NCT06141369

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +27 more
Locations: Ruijin hospital, Shanghai Jiao-Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT04119024

Conditions: Acral Melanoma, Adenocarcinoma, Adenocarcinoma of Lung, +59 more
Locations: City of Hope Duarte, California, United States

UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Stanford, California, United States

View Trial Details

Recruiting

Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma

NCT07335679

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
Locations: Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France Strasbourg, France

View Trial Details

Recruiting

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

NCT06333314

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
Locations: Institut de Cancérologie de l'Ouest Angers, France

Institut du Cancer Avignon-Provence Avignon, France

CHU Jean Minjoz Besançon, France

CHU Morvan Brest, France

View all 22 locations

View Trial Details

Recruiting

Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer

NCT07085572

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
Locations: S.C. Oncologia - ASST Spedali Civili di Brescia Brescia, Italy

View Trial Details

Recruiting

PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism

NCT07027254

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +13 more
Locations: Samsung Medical Center Seoul, Gangnam-gu, South Korea

Seoul National University Hospital Seoul, Jongno-gu, South Korea

View Trial Details

Recruiting

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

NCT06831175

Conditions: Adenocarcinoma, Adrenal Cancer, Adrenal Cortex Diseases, +13 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Recruiting

Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma

NCT06587802

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.

NCT05563467

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: Maria Sklodowska-Curie National Research Institute of Oncology Gliwice, Silesian Voivodeship, Poland

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie Cracow, Poland

Uniwersytecki Szpital Kliniczny W Poznaniu Poznan, Poland

Medical University Of Warsaw Warsaw, Poland

View Trial Details

Recruiting

Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)

NCT05913427

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: Alfredo Berruti Brescia, Italy

View Trial Details